X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Orchid Chemicals with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ORCHID PHARMA LTD vs AUROBINDO PHARMA - Comparison Results

ORCHID PHARMA LTD    Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ORCHID PHARMA LTD AUROBINDO PHARMA ORCHID PHARMA LTD/
AUROBINDO PHARMA
 
P/E (TTM) x -0.3 14.4 - View Chart
P/BV x 0.2 2.9 5.5% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 ORCHID PHARMA LTD   AUROBINDO PHARMA
EQUITY SHARE DATA
    ORCHID PHARMA LTD
Sep-13
AUROBINDO PHARMA
Mar-18
ORCHID PHARMA LTD/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs194809 24.0%   
Low Rs35504 6.9%   
Sales per share (Unadj.) Rs276.5281.1 98.4%  
Earnings per share (Unadj.) Rs-79.241.4 -191.5%  
Cash flow per share (Unadj.) Rs-43.550.9 -85.4%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Dividend yield (eoy) %00.4 0.0%  
Book value per share (Unadj.) Rs53.9199.4 27.1%  
Shares outstanding (eoy) m70.45585.88 12.0%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x0.42.3 17.7%   
Avg P/E ratio x-1.415.9 -9.1%  
P/CF ratio (eoy) x-2.612.9 -20.4%  
Price / Book Value ratio x2.13.3 64.5%  
Dividend payout %06.0 0.0%   
Avg Mkt Cap Rs m8,067384,630 2.1%   
No. of employees `0002.817.3 16.2%   
Total wages/salary Rs m2,52721,308 11.9%   
Avg. sales/employee Rs Th6,956.19,500.7 73.2%   
Avg. wages/employee Rs Th902.51,229.4 73.4%   
Avg. net profit/employee Rs Th-1,993.01,397.9 -142.6%   
INCOME DATA
Net Sales Rs m19,477164,666 11.8%  
Other income Rs m4071,020 39.9%   
Total revenues Rs m19,884165,686 12.0%   
Gross profit Rs m1,10337,718 2.9%  
Depreciation Rs m2,5195,580 45.1%   
Interest Rs m5,227777 672.5%   
Profit before tax Rs m-6,23632,380 -19.3%   
Minority Interest Rs m2031 62.7%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m5110-   
Tax Rs m-1258,183 -1.5%   
Profit after tax Rs m-5,58024,229 -23.0%  
Gross profit margin %5.722.9 24.7%  
Effective tax rate %2.025.3 7.9%   
Net profit margin %-28.714.7 -194.7%  
BALANCE SHEET DATA
Current assets Rs m11,014121,878 9.0%   
Current liabilities Rs m32,06086,806 36.9%   
Net working cap to sales %-108.121.3 -507.3%  
Current ratio x0.31.4 24.5%  
Inventory Days Days95130 73.1%  
Debtors Days Days3468 49.1%  
Net fixed assets Rs m29,44081,037 36.3%   
Share capital Rs m705586 120.2%   
"Free" reserves Rs m2,043116,218 1.8%   
Net worth Rs m3,800116,804 3.3%   
Long term debt Rs m9,0184,512 199.9%   
Total assets Rs m46,510211,052 22.0%  
Interest coverage x-0.242.7 -0.5%   
Debt to equity ratio x2.40 6,143.6%  
Sales to assets ratio x0.40.8 53.7%   
Return on assets %-0.811.8 -6.4%  
Return on equity %-146.920.7 -708.0%  
Return on capital %-3.727.4 -13.7%  
Exports to sales %37.90-   
Imports to sales %22.60-   
Exports (fob) Rs m7,378NA-   
Imports (cif) Rs m4,406NA-   
Fx inflow Rs m7,51380,727 9.3%   
Fx outflow Rs m5,64934,700 16.3%   
Net fx Rs m1,86546,027 4.1%   
CASH FLOW
From Operations Rs m1,68219,548 8.6%  
From Investments Rs m-9,860-19,570 50.4%  
From Financial Activity Rs m6,6448,642 76.9%  
Net Cashflow Rs m-1,5358,922 -17.2%  

Share Holding

Indian Promoters % 32.3 54.1 59.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.6 8.0 57.9%  
FIIs % 3.3 27.7 11.9%  
ADR/GDR % 4.6 0.0 -  
Free float % 55.3 10.2 542.2%  
Shareholders   84,811 69,601 121.9%  
Pledged promoter(s) holding % 54.9 8.6 641.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ORCHID PHARMA LTD With:   ELDER PHARMA  FDC LTD.  SHASUN PHARMA  DISHMAN PHARMA  TTK HEALTHCARE  

Compare ORCHID PHARMA LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 234 Points Higher; Healthcare and Realty Stocks Rally(Closing)

After opening the day on a flat note, Indian share markets witnessed buying interest during closing hours and ended higher.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (up 19.3% YoY). Sales on the other hand came in at Rs 53 bn (up 21.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

AUROBINDO PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 21.6% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (down 21.6% YoY). Sales on the other hand came in at Rs 48 bn (up 7.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

More Views on News

Most Popular

I Believe this is the Best Stock to Buy Today(Profit Hunter)

Jul 3, 2019

The languishing small cap space is currently offering a very fertile market to pick up bargains at very attractive prices. This is a perfect opportunity ripe for the picking.

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ORCHID PHARMA LTD SHARE PRICE


Jul 16, 2019 (Close)

TRACK ORCHID PHARMA LTD

  • Track your investment in ORCHID PHARMA LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ORCHID PHARMA LTD

ORCHID PHARMA LTD - FDC LTD. COMPARISON

COMPARE ORCHID PHARMA LTD WITH

MARKET STATS